RA

Rosalind Advisors Portfolio holdings

AUM $207M
1-Year Est. Return 62.29%
This Quarter Est. Return
1 Year Est. Return
+62.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$12.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$5.77M
2
+$5.41M
3
+$3.97M
4
OTLK icon
Outlook Therapeutics
OTLK
+$3.72M
5
UNCY icon
Unicycive Therapeutics
UNCY
+$2.59M

Top Sells

1
+$8.67M
2
+$5.78M
3
+$5.54M
4
CLRB icon
Cellectar Biosciences
CLRB
+$5.51M
5
LYRA icon
Lyra Therapeutics
LYRA
+$4.63M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$8M 7.48%
2,447,740
+527,830
2
$7.12M 6.65%
22,890
-14,884
3
$6.93M 6.47%
485,990
-120,761
4
$6.63M 6.2%
302,766
-22,939
5
$6.23M 5.82%
2,820,170
-723,515
6
$6.11M 5.71%
734,000
-64,500
7
$5.77M 5.39%
+367,368
8
$5.41M 5.06%
+378,416
9
$5.25M 4.91%
300,000
-60,332
10
$4.96M 4.63%
1,038,828
11
$4.55M 4.25%
533,333
12
$4.02M 3.76%
250,000
13
$3.97M 3.71%
+2,592,593
14
$3.72M 3.48%
+311,775
15
$3.42M 3.19%
287,985
-12,015
16
$3.19M 2.99%
926,016
-936,409
17
$3.15M 2.94%
450,000
+50,000
18
$2.59M 2.42%
+187,965
19
$2.47M 2.31%
20,716
-46,139
20
$1.91M 1.79%
+415,800
21
$1.63M 1.52%
686,062
-239,132
22
$1.62M 1.52%
+255,556
23
$1.57M 1.47%
+45,181
24
$1.41M 1.32%
+43,025
25
$1.22M 1.14%
607,797
1
2